Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Jacob H"'
Autor:
Bas de Laat, Marta Martinuzzo, Ian J. Mackie, Katrien Devreese, Hannah Cohen, Thomas L. Ortel, Philip G. de Groot, Emmanuel J. Favaloro, Jacob H. Rand, Denis Wahl, Vittorio Pengo, Armando Tripodi, Doruk Erkan
Publikováno v:
Journal of Thrombosis and Haemostasis. 18:2828-2839
This guidance focuses on methodological aspects of lupus anticoagulant (LA) testing, as well as interpretation of results for clinicians. The main changes in how to test for LA compared with the International Society on Thrombosis and Haemostasis Sci
Autor:
Jakob Schmidt Jensen, Christian Mirian, Irene Wessel, Christian Grønhøj, Kathrine Kronberg Jakobsen, K. Håkansson, Jacob H. Rasmussen, Mustafa Ghanizada, Christian von Buchwald
Publikováno v:
Acta oncologica (Stockholm, Sweden). 60(4)
The increasing incidence of oral cavity squamous cell carcinoma (OSCC) is challenging the capacity to treat patients efficiently. The aim of this study was to evaluate the impact of time to treatment initiation (TTI) on overall survival (OS) and recu
Publikováno v:
American Journal of Hematology. 95
Autor:
Matthew J. Maurer, Jacob H. Grauslund, Tove Wästerlid, Tarec Christoffer El-Galaly, Pär Josefsson, Lasse Hjort Jakobsen, Judit Jørgensen, Gita Thanarajasingam, Chan Yoon Cheah, Jon Bjørn, Harald Holte, Katherine Colvin, Jacob Haaber Christensen, Thomas M. Habermann, Yngvild Nuvin Blaker, Karin E. Smedby, Katie Y. Zhu, Ingemar Lagerlöf, Daniel Molin, Fredrik Ellin, Alina S. Gerrie, Andreas Kiesbye Øvlisen, Kevin W. Song, Knut B. Smeland
Publikováno v:
Jakobsen, L H, Ellin, F, Smeland, K B, Wästerlid, T, Christensen, J H, Jørgensen, J M, Josefsson, P L, Øvlisen, A K, Holte, H, Blaker, Y N, Grauslund, J H, Bjørn, J, Molin, D, Lagerlöf, I, Smedby, K E, Colvin, K, Thanarajasingam, G, Maurer, M J, Habermann, T M, Song, K W, Zhu, K Y, Gerrie, A S, Cheah, C Y & El-Galaly, T C 2020, ' Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients ', British Journal of Haematology. Supplement, vol. 189, no. 4, pp. 661-671 . https://doi.org/10.1111/bjh.16425
Jakobsen, L H, Ellin, F, Smeland, K B, Wästerlid, T, Christensen, J H, Jørgensen, J M, Josefsson, P L, Øvlisen, A K, Holte, H, Blaker, Y N, Grauslund, J H, Bjørn, J, Molin, D, Lagerlöf, I, Smedby, K E, Colvin, K, Thanarajasingam, G, Maurer, M J, Habermann, T M, Song, K W, Zhu, K Y, Gerrie, A S, Cheah, C Y & El-Galaly, T C 2020, ' Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients ', British Journal of Haematology, vol. 189, no. 4, pp. 661-671 . https://doi.org/10.1111/bjh.16425
Jakobsen, L H, Ellin, F, Smeland, K B, Wästerlid, T, Christensen, J H, Jørgensen, J M, Josefsson, P L, Øvlisen, A K, Holte, H, Blaker, Y N, Grauslund, J H, Bjørn, J, Molin, D, Lagerlöf, I, Smedby, K E, Colvin, K, Thanarajasingam, G, Maurer, M J, Habermann, T M, Song, K W, Zhu, K Y, Gerrie, A S, Cheah, C Y & El-Galaly, T C 2020, ' Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy : an international study of 264 real-world patients ', British Journal of Haematology, vol. 189, no. 4, pp. 661-671 . https://doi.org/10.1111/bjh.16425
Non-endemic Burkitt lymphoma (BL) is a rare germinal centre B-cell-derived malignancy with the genetic hallmark of MYC gene translocation and with rapid tumour growth as a distinct clinical feature. To investigate treatment outcomes, loss of lifetime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b06ef4714ed7f89c9d7439d43f1e4f
https://pure.au.dk/portal/da/publications/minimal-relapse-risk-and-early-normalization-of-survival-for-patients-with-burkitt-lymphoma-treated-with-intensive-immunochemotherapy(2ebd13a6-7c33-40b7-8ca2-3a2c0b6eebee).html
https://pure.au.dk/portal/da/publications/minimal-relapse-risk-and-early-normalization-of-survival-for-patients-with-burkitt-lymphoma-treated-with-intensive-immunochemotherapy(2ebd13a6-7c33-40b7-8ca2-3a2c0b6eebee).html
Autor:
Lena Specht, Mingyao Zhu, Ivan R. Vogelius, Søren M. Bentzen, B. Smulders, K. Håkansson, Jacob H. Rasmussen, Jeppe Friborg
Background: Dose-painting has recently been investigated in early-phase trials in head-and-neck cancer (HNC) with the aim of improving local tumor control. At the same time proton therapy has been reported as potentially capable of decreasing toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003db7b344069171119332758102e3cc
Autor:
Jeppe Friborg, Søren M. Bentzen, K. Håkansson, Lena Specht, Ivan R. Vogelius, Jacob H. Rasmussen
Publikováno v:
Acta Oncologica. 58:390-392
Loco-regional control (LRC) and disease-free-survival (DFS) are important clinical endpoints in head-and-neck cancer (HNC). However, an improvement in LRC cannot be expected to translate directly i...
Publikováno v:
Radiotherapy and Oncology. 152:S302-S303
Autor:
Gregers Brünnich Rasmussen, K. Håkansson, Jeppe Friborg, Jacob H. Rasmussen, Ivan R. Vogelius, Marianne Hamilton Therkildsen, Kevin J. Cullen, Lena Specht, Søren M. Bentzen, Barbara M. Fischer, Lisa M. Schumaker
Publikováno v:
Acta Oncologica. 56:1562-1570
To identify a failure site-specific prognostic model by combining immunohistochemistry (IHC) and molecular imaging information to predict long-term failure type in squamous cell carcinoma of the head and neck.Tissue microarray blocks of 196 head and
Autor:
Claus Wittekindt, C. von Buchwald, Christian Grønhøj, Elo Andersen, K. Håkansson, Jacob H. Rasmussen, Ivan R. Vogelius, Steffen Wagner, Jens Peter Klussmann, Jeppe Friborg, Giedrius Lelkaitis
Publikováno v:
Rasmussen, J H, Grønhøj, C, Håkansson, K, Friborg, J, Andersen, E, Lelkaitis, G, Klussmann, J P, Wittekindt, C, Wagner, S, Vogelius, I R & von Buchwald, C 2019, ' Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma ', Annals of Oncology, vol. 30, no. 4, pp. 629-636 . https://doi.org/10.1093/annonc/mdz010
BACKGROUND: In the era of precision medicine and HPV-related oropharyngeal squamous cell carcinoma (OPSCC), it is relevant to assess the risk of not only survival, but also the risk of local, regional, or distant treatment failure. The UICC 8th editi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7ae4423ec37db320d7dc912e3aa6de
https://curis.ku.dk/ws/files/237192797/1_s2.0_S0923753419311093_main.pdf
https://curis.ku.dk/ws/files/237192797/1_s2.0_S0923753419311093_main.pdf
Autor:
Martin Zamani, Jacob H. Rasmussen, Jeppe Friborg, L. Specht, A.M. Lindegaard, C. Von Buchwald, Ivan R. Vogelius
Publikováno v:
Radiotherapy and Oncology. 152:S22